Safehouse, the nonprofit behind Philadelphia’s proposed supervised injection facility, is waiting on a federal judge to determine whether it’s legal to open the first medical site of its kind in the U ...
The pharmaceutical company Gilead has announced that its new pre-exposure prophylactic (PrEP) injectable medication has passed a Phase III clinical trial demonstrating its safety and effectiveness ...
GARTNER SECURITY & RISK MANAGEMENT SUMMIT — Washington, DC — Having awareness and provenance of where the code you use comes from can be a boon to prevent supply chain attacks, according to GitHub's ...